Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 The impact of racial, geographic, and socioeconomic risk factors on the development of advanced-stage cervical cancer.  Journal of Lower Genital Tract Disease.  22:269-273. 2018
2018 Cost effectiveness of neoadjuvant chemotherapy followed by interval cytoreductive surgery versus primary cytoreductive surgery for patients with advanced stage ovarian cancer during the initial treatment phase.  Gynecologic Oncology.  148:329-335. 2018
2018 A ketogenic diet reduces central obesity and serum insulin in women with ovarian or endometrial cancer.  Journal of Nutrition.  148:1253-1260. 2018
2017 Prior breast cancer and tamoxifen exposure does not influence outcomes in women with uterine papillary serous carcinoma..  Gynecologic Oncology.  144:531-535. 2017
2016 Does the Robotic Platform Reduce Morbidity Associated With Combined Radical Surgery and Adjuvant Radiation for Early Cervical Cancers?.  International Journal of Gynecological Cancer.  26:1485-1489. 2016
2016 The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia..  American Journal of Criminal Justice.  215:217.e1-217.e5. 2016
2016 Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma..  International Journal of Gynecological Cancer.  26:505-511. 2016
2016 Reply.  American Journal of Criminal Justice.  214:296-297. 2016
2016 Phase 1b safety study of farletuzumab, carboplatin and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer.  Gynecologic Oncology.  140:210-214. 2016
2015 Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis Of The Aurelia Trial..  Value in Health.  18:A461. 2015
2015 Obesity and perioperative pulmonary complications in robotic gynecologic surgery.  American Journal of Criminal Justice.  213. 2015
2014 Building a successful fertility preservation program at a major cancer center..  Journal of Gynecologic Oncology.  25:148-154. 2014
2014 Compliance rates and outcomes associated with a restrictive transfusion policy in gynecologic oncology patients.  Gynecologic Oncology.  132:227-230. 2014
2014 Monitoring of biodistribution and persistence of conditionally replicative adenovirus in a murine model of ovarian cancer using capsid-incorporated mCherry and expression of human somatostatin receptor subtype 2 gene.  Molecular Imaging.  13. 2014
2013 A phase i clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.  Gynecologic Oncology.  130:518-524. 2013
2013 Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients..  Gynecologic Oncology.  130:152-155. 2013
2013 Pre-operative imaging with CA125 is a poor predictor for granulosa cell tumors.  Gynecologic Oncology.  131:59-62. 2013
2012 Management of complex pelvic masses using a multivariate index assay: A decision analysis.  Gynecologic Oncology.  126:364-368. 2012
2012 Completed versus aborted radical hysterectomy for node-positive stage IB cervical cancer in the modern era of chemoradiation therapy.  Gynecologic Oncology.  126:69-72. 2012
2012 A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancer.  Current Obesity Reports.  18:3440-3451. 2012
2012 Using a multivariate index assay to assess malignancy in a pelvic mass.  Obstetrics and Gynecology.  119:365-367. 2012
2011 Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.  Gynecologic Oncology.  123:54-57. 2011
2011 A cohort study evaluating robotic versus laparotomy surgical outcomes of obese women with endometrial carcinoma.  Gynecologic Oncology.  122:604-607. 2011
2011 A new generation of serotype chimeric infectivity-enhanced conditionally replicative adenovirals: The safety profile of Ad5/3-Δ24 in advance of a phase i clinical trial in ovarian cancer patients.  Human Gene Therapy.  22:821-828. 2011
2011 Abnormally low hCG in a complete hydatidiform molar pregnancy: The hook effect.  Gynecologic Oncology Case Reports.  1:6-7. 2011
2009 Early-stage endometrial cancer: Is adjuvant radiation really warranted?.  The Journal of behavioral economics.  2:90-93. 2009
Extremes in body mass index affect overall survival in women with cervical cancer..  Gynecologic Oncology.  141:497-500.

Chapter

Year Title Altmetric
2013 Preinvasive disease of the lower genital tract.  129-150. 2013

Research Overview

  • Development novel, evidence-based surgical education and curricula, as well as the application of novel techniques and technologies to improve surgical education and outcomes, particularly through the use of quantitative and objective metrics during acquisition of surgical technique.

    • Principal Investigator On

  • Private Grant  awarded by LICOR, INC. 2017 - 2019

    • Investigator On

    Education And Training

  • Doctor of Medicine, Medical College of Ohio 2005
  • Bachelor of Arts in Miscellaneous Biological Specializations, Swarthmore College 2001
  • Ohio State University Medical Center, Residency 2009
  • UAB Hospital, Postdoctoral Fellowship 2012

    • Full Name

  • Kenneth Kim